Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations

Annals of Thoracic Surgery

Volumn 93, Issue 6, 2012, Pages 1921-1929

  Andersen, Nicholas D ^a   Bhattacharya, Syamal D ^a   Williams, Judson B ^a   Fosbol, Emil L ^a   Lockhart, Evelyn L ^a   Patel, Mayur B ^b   Gaca, Jeffrey G ^a   Welsby, Ian J ^a   Hughes, G Chad ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEMOSTATIC AGENT; RECOMBINANT ACTIVATED FACTOR 7; UNCLASSIFIED DRUG; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONTROL GROUP; DRUG USE; FEMALE; HEART INFARCTION; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRAOPERATIVE PERIOD; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PATIENT SELECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SAFETY; STROKE; THORACIC AORTA SURGERY; THROMBOEMBOLISM;

AGED; AORTA, THORACIC; BLOOD COAGULATION TESTS; BLOOD TRANSFUSION; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIOPULMONARY BYPASS; COHORT STUDIES; CRITICAL PATHWAYS; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR VIIA; FEMALE; HEART ARREST, INDUCED; HEMOSTASIS, SURGICAL; HOSPITAL COSTS; HUMANS; INTRAOPERATIVE PERIOD; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROPENSITY SCORE; RECOMBINANT PROTEINS;

EID: 84861637174     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.02.037     Document Type: Article

References (21)

1. P. Diprose, M.J. Herbertson, D. O'Shaughnessy, R.S. Gill Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study Br J Anaesth 95 2005 596 602
2. K. Karkouti, W.S. Beattie, D.N. Wijeysundera Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis Transfusion 45 2005 26 34
3. L. Tritapepe, V. De Santis, D. Vitale Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis Crit Care Med 35 2007 1685 1690
4. S. Gelsomino, R. Lorusso, S. Romagnoli Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis Eur J Cardiothorac Surg 33 2008 64 71
5. F. Masud, F. Bostan, E. Chi Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes J Cardiothorac Vasc Anesth 23 2009 28 33
6. R. Gill, M. Herbertson, A. Vuylsteke Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery Circulation 120 2009 21 27
7. J. Tatoulis, S. Theodore, M. Meswani Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery Interact Cardiovasc Thorac Surg 9 2009 459 462
8. W.E. Uber, J.M. Toole, M.R. Stroud Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes J Thorac Cardiovasc Surg 141 2011 1469 1477 e1462
9. M. Hacquard, M. Durand, T. Lecompte Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7) Eur J CardiothoracSurg 40 2011 1320 1327
10. C. von Heymann, U. Redlich, U. Jain Recombinant activated factor VII for refractory bleeding after cardiac surgery - a retrospective analysis of safety and efficacy Crit Care Med 33 2005 2241 2246
11. K. Karkouti, W.S. Beattie, R. Arellano Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery Circulation 118 2008 331 338
12. B. Mitra, L. Phillips, P.A. Cameron, B. Billah, C. Reid The safety of recombinant factor VIIa in cardiac surgery Anaesth Intensive Care 38 2010 671 677
13. A.J. Chapman, A.L. Blount, A.T. Davis, R.L. Hooker Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery Eur J Cardiothorac Surg 40 2011 1314 1318 discussion 1318-9
14. M. Ponschab, G. Landoni, G. Biondi-Zoccai Recombinant activated factor VII increases stroke in cardiac surgery: a meta-analysis J Cardiothorac Vasc Anesth 25 2011 804 810
15. I.J. Welsby, D.M. Monroe, J.H. Lawson, M. Hoffmann Recombinant activated factor VII and the anaesthetist Anaesthesia 60 2005 1203 1212
16. J.B. Williams, B. Phillips-Bute, S.D. Bhattacharya Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest J Thorac Cardiovasc Surg 141 2011 1283 1288
17. B. Lima, J.B. Williams, S.D. Bhattacharya Results of proximal arch replacement using deep hypothermia for circulatory arrest: is moderate hypothermia really justifiable? Am Surg 77 2011 1438 1444
18. E.M. van de Garde, L.J. Bras, R.H. Heijmen Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients J Cardiothorac Vasc Anesth 20 2006 573 575
19. C. Willis, R. Bird, D. Mullany, P. Cameron, L. Phillips Use of rFVIIa for critical bleeding in cardiac surgery: dose variation and patient outcomes Vox Sang 98 2010 531 537
20. R. Altman, A. Scazziota, M. de Lourdes Herrera, C.D. Gonzalez The hemostatic profile of recombinant activated factor VII Can low concentrations stop bleeding in off-label indications? Thromb J 8 2010 8
21. T. Syburra, M. Lachat, M. Genoni, M.J. Wilhelm Fatal outcome of recombinant factor VIIa in heart transplantation with extracorporeal membrane oxygenation Ann Thorac Surg 89 2010 1643 1645